Medi Peptide
Retatrutide
Finnrick tested 4 samples of Retatrutide (GLP-1, GIP, and GCGR agonist) from Medi Peptide between 6 May 2026 and 18 Aug 2026. Test scores average over 7, no score below 6, and at least 2 tests warrant a tentative Finnrick Rating of A (Great).
Finnrick Rating™
Tentative Rating
Medi Peptide
Retatrutide
Tested 4 Samples
Last test 18 Aug 2026
Take Action
Free peptide testing
Mail in a sample (US only) to get confidence for the specific vials you have, and contribute to identifying unsafe supply chains, so other people can avoid risky and costly mistakes.
Other Retatrutide tests from top-rated vendors:
All Retatrutide tests from Medi Peptide
Samples are tested in commercial labs
Tests Count
4
Scores
AVGMINMAX
Last
18 Aug 2026
First
6 May 2026
| Quantity | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Test Date | Certificate | Test Score | Label | Tested | Difference | Purity | Batch ID | Container | Tested At | Sent By |
| 18 Aug 2026 | View | 20mg | 20.2mg | +1.0% | 99.80% | RT20-08-024, MARCH 2026 | Silver label / Silver crimp / Blue cap | Lab G | Public | |
| 30 Jul 2026 | View | 10mg | 8.6mg | -14.0% | 99.60% | March 25 2026 | No label / Silver crimp / Black cap | Lab G | Public | |
| 15 Jul 2026 | View | 20mg | 22.4mg | +12.0% | 99.80% | May/1/2026 | Silver Label / Silver Crimp / Blue Cap | Lab G | Public | |
| 6 May 2026 | View | 10mg | 16.3mg | +63.0% | 99.90% | 114319 | No Label / Silver Crimp / Purple Cap | Lab E | Public | |